Bio-CDMOs: How Can Manufacturers Scale Complex Biologics?
Frost & Sullivan Podcasts
In this episode of Frost & Sullivan's Growth Podcast, we delve into the evolving landscape of biologics contract development and manufacturing organizations (bioCDMOs). With biologic drugs growing increasingly complex, I discuss how these organizations are adapting to meet rising manufacturing demands and shifting investment priorities. We'll explore the critical strategic imperatives shaping the industry, including competitive intensity, geopolitical uncertainties, and disruptive technologies. I also highlight the importance of specialized capabilities and reliable operating models that bioCDMOs must embrace to succeed. Tune in as we unpack the future of biologics manufacturing and what it means for pharmaceutical and biotechnology companies navigating this intricate terrain.
Loading